Replies to post #584513 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

Edited-Totally agree. She mentioned about the numbers to be 1 Million pages. If there was added scope to the existing documents per regulators, she should have Dave informed the shareholders about this change just to calm the shareholders after so many years of waiting. Instead, the shorts are having a blast day to play with PPS. Sometimes to be too quiet have an opposite impact. There are times we need to be quite which we already passed that once we published in JAMA and there are times, we need to be active in communication.

This is my opinion based on my observation in past couple of years. NWBO is a very small company with great products that save lives. Cancer patients are dying. For sake of patients' community why not sell this company for a reasonable price like $6-8 and have someone else bring those two products to the market or some other ways thru partnership with less loyalty. I know some people are looking for way more than that. Everyone will be making money including folks with less shares.

[jfr1611]

1M pages was in dec at the ASM.
She also said ~250k pages per month.
Jan 250k pages
Feb 250 pages

Saying 1,5m pages at submission is accurate imo.

[MasterKit]

From ASM-

So there's a trial master file. And there are case report forms that contain the patient data. There are batch manufacturing records from each individual product that's been manufactured. Overall, the documents could be in the range of 1 million pages. And these pages have to be gone through by humans and they have to be checked and checked for any gaps, inconsistencies, anything so that this body of documents, some of which will go in the application package and some of which will be supportive and have to be inspection-ready, all have to be up to snuff and pass muster with inspection by regulators.